National Bank of Canada’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4
Closed -$54 3061
2025
Q2
$54 Buy
+4
New +$38 ﹤0.01% 2898
2024
Q3
Sell
-750
Closed -$5.09K 2923
2024
Q2
$5.09K Hold
750
﹤0.01% 2256
2024
Q1
$6.97K Sell
750
-250
-25% -$1.85K ﹤0.01% 2248
2023
Q4
$8.4K Hold
1,000
﹤0.01% 2206
2023
Q3
$6.24K Hold
1,000
﹤0.01% 2309
2023
Q2
$4.3K Hold
1,000
﹤0.01% 2370
2023
Q1
$1.66K Hold
1,000
﹤0.01% 2470
2022
Q4
$1.92K Hold
1,000
﹤0.01% 2495
2022
Q3
$2K Hold
1,000
﹤0.01% 2508
2022
Q2
$2K Buy
+1,000
New +$2.48K ﹤0.01% 2597

Other funds holding LFMD

National Bank of Canada's LFMD Position: Q3 2025 in Review

National Bank of Canada sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 4 shares — an estimated $54 sold.

National Bank of Canada first reported a position in LFMD in Q2 2022 and held it in 10 quarters. The position peaked at $8.4K in Q4 2023. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

  • National Bank of Canada reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
  • National Bank of Canada sold 4 LifeMD shares in Q3 2025, an estimated $54.
  • National Bank of Canada first reported a position in LifeMD in Q2 2022 and held it in 10 quarters.
  • National Bank of Canada's LifeMD position peaked at $8.4K in Q4 2023.
  • 114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on National Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.